{"disease":{"id":"cd79b-gene-mutation","name":"cd79b gene mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04668365","title":"Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":59,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT04994626","title":"Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}